Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study

OBJECTIVE: In a number of controlled clinical trials and naturalistic studies, aripiprazole once monthly (AOM) has been found to be effective and safe as acute and maintenance treatment options for schizophrenia. However, such clinical data have been presented in selected patient population (i.e., a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Psychopharmacol Neurosci
Autors principals: Pae, Chi-Un, Han, Changsu, Bahk, Won-Myong, Lee, Soo-Jung, Patkar, Ashwin A., Masand, Prakash S.
Format: Artigo
Idioma:Inglês
Publicat: Korean College of Neuropsychopharmacology 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8077057/
https://ncbi.nlm.nih.gov/pubmed/33888652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9758/cpn.2021.19.2.233
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars